Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care Sites
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofac293
Abstract: Abstract Use of long-acting injectable antiretroviral therapy depends on patient awareness, provider discussion, and patient willingness to use. We conducted a postvisit survey with patients at 3 HIV clinics in San Francisco, Chicago, and Atlanta… read more here.
Keywords: patients providers; antiretroviral therapy; injectable antiretroviral; acting injectable ... See more keywords
High willingness to use injectable antiretroviral therapy among women who have been lost to follow‐up from HIV programmes: A nested cross‐sectional study
Sign Up to like & getrecommendations! Published in 2022 at "HIV Medicine"
DOI: 10.1111/hiv.13260
Abstract: Efforts to achieve zero transmission of HIV to infants born to women living with HIV in sub‐Saharan African are undermined by high rates of loss to follow‐up in prevention of vertical transmission (PVT) programmes. The… read more here.
Keywords: hiv; among women; antiretroviral therapy; injectable antiretroviral ... See more keywords